Patrick Soon

Insider Reports History

Entity
Individual
Location
9922 Jefferson Boulevard, Culver City, CA
Signature
/s/ Patrick Soon-Shiong,
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Patrick Soon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ImmunityBio, Inc. Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner Common Stock 32.6M $164M $5.02 Sep 11, 2023 Indirect
ImmunityBio, Inc. Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner Common Stock 29.5M $148M $5.02 Sep 11, 2023 Direct
NantHealth, Inc. Chief Executive Officer, Director, 10%+ Owner Common Stock 15.9M $6.21M $0.39 Aug 28, 2023 Indirect
ImmunityBio, Inc. Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner Restricted Stock Units 343K $1.39M $4.04 Feb 22, 2024 Direct
ImmunityBio, Inc. Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner Stock Option (right to buy) 1.19M Feb 22, 2024 Direct
ImmunityBio, Inc. Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner Amended and Restated Convertible Promissory Note $0 Sep 11, 2023 Indirect
ImmunityBio, Inc. Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner Amended and Restated Promissory Note $380M Dec 29, 2023 Indirect
ImmunityBio, Inc. Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner Convertible Promissory Note $30M Dec 29, 2023 Indirect
ImmunityBio, Inc. Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner Second Amended and Restated Convertible Promissory Note $0 Sep 11, 2023 Indirect

Insider Reports Filed by Patrick Soon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IBRX ImmunityBio, Inc. Feb 22, 2024 2 $0 4 Feb 26, 2024 Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner
IBRX ImmunityBio, Inc. Dec 29, 2023 2 $410M 4 Jan 3, 2024 Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner
IBRX ImmunityBio, Inc. Sep 11, 2023 9 $200M 4 Sep 13, 2023 Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner
NHIQ NantHealth, Inc. Aug 28, 2023 2 $16M 4 Aug 30, 2023 Chief Executive Officer, Director, 10%+ Owner
IBRX ImmunityBio, Inc. May 12, 2023 1 $30.5M 4 May 16, 2023 Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner
IBRX ImmunityBio, Inc. Dec 12, 2022 2 -$5 4 Dec 14, 2022 Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner
IBRX ImmunityBio, Inc. Aug 31, 2022 6 $315M 4 Nov 8, 2022 Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner
IBRX ImmunityBio, Inc. Mar 23, 2022 2 $0 4 Mar 25, 2022 Executive Chairman, Director, 10%+ Owner
NHIQ NantHealth, Inc. Sep 9, 2021 1 $0 4 Sep 13, 2021 Chairman and CEO, Director, 10%+ Owner
IBRX ImmunityBio, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Executive Chairman, Director, 10%+ Owner